Bumper Offer - Urjas oil Just @ Rs. 1
Mirtaz 7.5 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Depression.
The right dosage of Mirtaz 7.5 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Mirtaz 7.5 Tablet include Dry Mouth, Headache, Weight gain. Some other side effects of Mirtaz 7.5 Tablet have been listed ahead. These side effects of Mirtaz 7.5 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Mirtaz 7.5 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Mirtaz 7.5 Tablet related warnings talks about Mirtaz 7.5 Tablet's effects on the liver, heart and kidney.
Mirtaz 7.5 Tablet is contraindicated in people with pre-existing medical conditions like Suicidal Tendency, Kidney Disease, Heart Disease as it can result in adverse effects. Other conditions have been mentioned below in the Mirtaz 7.5 Tablet contraindications section.
Drug interactions for Mirtaz 7.5 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Mirtaz 7.5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Mirtaz 7.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Mirtaz 7.5 Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Mirtaz 7.5 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Mirtaz. It is best to stop taking Mirtaz immediately and inform your doctor if you notice any discomfort.
Is the use of Mirtaz 7.5 Tablet safe during breastfeeding?
Mirtaz may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Mirtaz 7.5 Tablet on the Kidneys?
Very few cases of side effects of Mirtaz on kidney have been reported.
What is the effect of Mirtaz 7.5 Tablet on the Liver?
Mirtaz is rarely harmful for the liver.
What is the effect of Mirtaz 7.5 Tablet on the Heart?
Very few cases of side effects of Mirtaz on the heart have been reported.
Mirtaz 7.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mirtaz 7.5 Tablet unless your doctor advises you to do so -
Is this Mirtaz 7.5 Tablet habit forming or addictive?
No, you will not get addicted to Mirtaz 7.5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mirtaz 7.5 Tablet can make you feel drowsy.
Is it safe?
Mirtaz 7.5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, Mirtaz 7.5 Tablet is useful in treating mental disorders.
Interaction between Food and Mirtaz 7.5 Tablet
It is safe to take Mirtaz 7.5 Tablet with food.
Interaction between Alcohol and Mirtaz 7.5 Tablet
Taking Mirtaz 7.5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 865-866
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462-463
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Remeron® (mirtazapine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 865-866
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462-463
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Remeron® (mirtazapine)